Controlling inflammation: A fat chance?

Journal of Experimental Medicine

Volumn 201, Issue 5, 2005, Pages 671-674

  Flower, Roderick J ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANNEXIN 1; ANTIINFLAMMATORY AGENT; FISH OIL; G PROTEIN COUPLED RECEPTOR; ICOSAPENTAENOIC ACID; POLYUNSATURATED FATTY ACID; PROTEIN DERIVATIVE; RESOLVIN E1; UNCLASSIFIED DRUG;

DIET; DIET SUPPLEMENTATION; HUMAN; IMMUNITY; INFECTION; INFLAMMATION; INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPIRIN; DIETARY FATS; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 15444362815     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050222     Document Type: Review

References (35)

1. Burr, G., and M. Burr. 1930. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 86:587-621.
2. Bergstrom, S., H. Danielsson, and B. Samuelsson. 1964. The enzymatic formation of prostaglandin E2 from arachidonic acid. Biochim. Biophys. Acta. 90:207-210.
3. Samuelsson, B., and S. Hammarstrom. 1982. Leukotrienes: a novel group of biologically active compounds. Vitam. Horm. 39:1-30.
4. Devane, W.A., L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1946-1949.
5. Simopoulos, A.P. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54:438-463.
6. Lands, W., P. LeTellier, L. Rome, and J. Vanderhoek. 1973. Inhibition of prostaglandin biosynthesis. In International Conference on Prostaglandins. S.B.a.S. Bernhard, editor. Pergamon Press Vieweg, Braunschweig, Germany. 15-28.
7. Bagga, D., L. Wang, R. Farias-Eisner, J.A. Glaspy, and S.T. Reddy. 2003. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA. 100:1751-1756.
8. Terano, T., J.A. Salmon, and S. Moncada. 1984. Effect of orally administered eicosapentaenoic acid (EPA) on the formation of leukotriene B4 and leukotriene B5 by rat leukocytes. Biochem. Pharmacol. 33:3071-3076.
9. Das, U.N. 2000. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot. Essent. Fatty Acids. 63:351-362.
10. Adam, O. 2003. Dietary fatty acids and immune reactions in synovial tissue. Eur. J. Med. Res. 8:381-387.
11. De Vizia, B., V. Raia, C. Spano, C. Pavlidis, A. Coruzzo, and M. Alessio. 2003. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J. Patenter. Enteral Nutr. 27:52-57.
12. Stenson, W.F., D. Core, J. Rodgers, R. Burakoff, K. DeSchryver- Kecskemeti, T.L. Gramlich, and W. Beeken. 1992. Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med. 116:609-614.
13. Rhodes, L.E., B.H. Durham, W.D. Fraser, and P.S. Friedmann. 1995. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J. Invest. Dermatol. 105:532-535.
14. Mayer, K., C. Fegbeutel, K. Hattar, U. Sibelius, H.J. Kramer, K.U. Heuer, B. Temmesfeld-Wollbruck, S. Gokorsch, F. Grimminger, and W. Seeger. 2003. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 29: 1472-1481.
15. Dry, J., and D. Vincent. 1991. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int. Arch. Allergy Appl. Immunol. 95:156-157.
16. Berstad, P., I. Seljeflot, M.B. Veierod, E.M. Hjerkinn, H. Amesen, and J.I. Pedersen. 2003. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin. Sci. (Lond.). 105:13-20.
17. Lawrence, R., and T. Sorrell. 1993. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4. Lancet. 342:465-469.
18. Terano, T., J.A. Salmon, G.A. Higgs, and S. Moncada. 1986. Eicosapentaenoic acid as a modulator of inflammation. Effect on prostaglandin and leukotriene synthesis. Biochem. Pharmacol. 35:779-785.
19. Adam, O., C. Beringer, T. Kless, C. Lemmen, A. Adam, M. Wiseman, P. Adam, R. Klimmek, and W. Forth. 2003. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int. 23:27-36.
20. Sethi, S. 2002. Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil. Redox Rep. 7:369-378.
21. Barham, J.B., M.B. Edens, A.N. Fonteh, M.M. Johnson, L. Easter, and F.H. Chilton. 2000. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J. Nutr. 130:1925-1931.
22. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan. 2005. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J. Exp. Med. 201:713-722.
23. Serhan, C.N., K. Gotlinger, S. Hong, and M. Arita. 2004. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 73:155-172.
24. Serhan, C.N., C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert. 2000. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192:1197-1204.
25. Bhattacharyya, D.K., M. Lecomte, J. Dunn, D.J. Morgans, and W.L. Smith. 1995. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch. Biochem. Biophys. 317: 19-24.
26. Chiang, N., I.M. Fierro, K. Gronert, and C.N. Serhan. 2000. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191: 1197-1208.
27. Le, Y., P.M. Murphy, and J.M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23:541-548.
28. Perretti, M., N. Chiang, M. La, I.M. Fierro, S. Marullo, S.J. Getting, E. Solito, and C.N. Serhan. 2002. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8:1296-1302.
29. Christopoulos, A., and T. Kenakin. 2002. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54:323-374.
30. Bae, Y.S., J.Y. Song, Y. Kim, R. He, R.D. Ye, J.Y. Kwak, P.G. Suh, and S.H. Ryu. 2003. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol. Pharmacol. 64:841-847.
31. Perretti, M., and F.N. Gavins. 2003. Annexin 1: an endogenous anti-inflammatory protein. News Physiol. Sci. 18:60-64.
32. Gilroy, D.W., T. Lawrence, M. Perretti, and A.G. Rossi. 2004. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3:401-416.
33. Serhan, C.N., and N. Chiang. 2002. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. Scientific-WorldJournal. 2:169-204.
34. Paul-dark, M.J., T. Van Cao, N. Moradi-Bidhendi, D. Cooper, and D.W. Gilroy. 2004. 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200: 69-78.
35. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 354:447-455.